APO RESEARCH · REPORT
Oxyclozanide
Oxyclozanide is a salicylanilide anthelmintic. It is used in the treatment and control of fascioliasis in ruminants mainly domestic animals such as cattle, sheep, and goats. It mainly acts by uncoupling of oxidative phosphorylation in flukes.
Product & engineering
Understand the product.
Oxyclozanide is a salicylanilide anthelmintic. It is used in the treatment and control of fascioliasis in ruminants mainly domestic animals such as cattle, sheep, and goats. It mainly acts by uncoupling of oxidative phosphorylation in flukes.
Selected research
Market Structure
Global Oxyclozanide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Oxyclozanide is a salicylanilide anthelmintic. It is used in the treatment and control of fascioliasis in ruminants mainly domestic animals such as cattle, sheep, and goats. It mainly acts by uncoupling of oxidative phosphorylation in flukes.
Global Oxyclozanide main players are Siflon Drug, Yabang, Gharda, ASCENT PHARMA, Aarambh Life Science, etc. Top five companies hold a share above 50%. Africa is the largest market, with a share about 30%.
This report provides an overview of the global Oxyclozanide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
Read the full market overview
The study covers key producers of Oxyclozanide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Oxyclozanide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oxyclozanide market size, projected growth trends, production technologies, key applications, and end-use industries.
Oxyclozanide Segment by Company
Siflon Drugs
Yabang
Gharda
ASCENT PHARMA
Aarambh Life Science
ProVentus
Excel Industries
Konar Organics
Neha Pharma
D. H. Organics
Neeta Interchem
Oxyclozanide Segment by Type
Content 98%
Content 99%
Oxyclozanide Segment by Application
Injectables
Oral Liquids
Feed Additives
Oxyclozanide Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxyclozanide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxyclozanide and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxyclozanide.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Oxyclozanide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oxyclozanide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oxyclozanide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Oxyclozanide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Content 98%
- Content 99%
Applications
- Injectables
- Oral Liquids
- Feed Additives
Companies covered
- Siflon Drugs
- Yabang
- Gharda
- ASCENT PHARMA
- Aarambh Life Science
- ProVentus
- Excel Industries
- Konar Organics
- Neha Pharma
- D. H. Organics
- Neeta Interchem
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Oxyclozanide Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Oxyclozanide Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Oxyclozanide Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Oxyclozanide Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Oxyclozanide Market Dynamics
- 2.1 Oxyclozanide Industry Trends
- 2.2 Oxyclozanide Industry Drivers
- 2.3 Oxyclozanide Industry Opportunities and Challenges
- 2.4 Oxyclozanide Industry Restraints
3 Oxyclozanide Market by Manufacturers
- 3.1 Global Oxyclozanide Revenue by Manufacturers (2021-2026)
- 3.2 Global Oxyclozanide Sales by Manufacturers (2021-2026)
- 3.3 Global Oxyclozanide Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Oxyclozanide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Oxyclozanide Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Oxyclozanide Manufacturers, Product Type & Application
- 3.7 Global Oxyclozanide Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Oxyclozanide Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Oxyclozanide Players Market Share by Revenue in 2025
- 3.8.3 2025 Oxyclozanide Tier 1, Tier 2, and Tier 3
4 Oxyclozanide Market by Type
- 4.1 Oxyclozanide Type Introduction
- 4.1.1 Content 98%
- 4.1.2 Content 99%
- 4.2 Global Oxyclozanide Sales by Type
- 4.2.1 Global Oxyclozanide Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Oxyclozanide Sales by Type (2021-2032)
- 4.2.3 Global Oxyclozanide Sales Market Share by Type (2021-2032)
- 4.3 Global Oxyclozanide Revenue by Type
- 4.3.1 Global Oxyclozanide Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Oxyclozanide Revenue by Type (2021-2032)
- 4.3.3 Global Oxyclozanide Revenue Market Share by Type (2021-2032)
5 Oxyclozanide Market by Application
- 5.1 Oxyclozanide Application Introduction
- 5.1.1 Injectables
- 5.1.2 Oral Liquids
- 5.1.3 Feed Additives
- 5.2 Global Oxyclozanide Sales by Application
- 5.2.1 Global Oxyclozanide Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Oxyclozanide Sales by Application (2021-2032)
- 5.2.3 Global Oxyclozanide Sales Market Share by Application (2021-2032)
- 5.3 Global Oxyclozanide Revenue by Application
- 5.3.1 Global Oxyclozanide Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Oxyclozanide Revenue by Application (2021-2032)
- 5.3.3 Global Oxyclozanide Revenue Market Share by Application (2021-2032)
6 Global Oxyclozanide Sales by Region
- 6.1 Global Oxyclozanide Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Oxyclozanide Sales by Region (2021-2032)
- 6.2.1 Global Oxyclozanide Sales by Region (2021-2026)
- 6.2.2 Global Oxyclozanide Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Oxyclozanide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Oxyclozanide Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Oxyclozanide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Oxyclozanide Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Oxyclozanide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Oxyclozanide Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Oxyclozanide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Oxyclozanide Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Oxyclozanide Revenue by Region
- 7.1 Global Oxyclozanide Revenue by Region
- 7.1.1 Global Oxyclozanide Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Oxyclozanide Revenue by Region (2021-2026)
- 7.1.3 Global Oxyclozanide Revenue by Region (2027-2032)
- 7.1.4 Global Oxyclozanide Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Oxyclozanide Revenue (2021-2032)
- 7.2.2 North America Oxyclozanide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Oxyclozanide Revenue (2021-2032)
- 7.3.2 Europe Oxyclozanide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Oxyclozanide Revenue (2021-2032)
- 7.4.2 Asia-Pacific Oxyclozanide Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Oxyclozanide Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Oxyclozanide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Siflon Drugs
- 8.1.1 Siflon Drugs Company Information
- 8.1.2 Siflon Drugs Business Overview
- 8.1.3 Siflon Drugs Oxyclozanide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Siflon Drugs Oxyclozanide Product Portfolio
- 8.1.5 Siflon Drugs Recent Developments
- 8.2 Yabang
- 8.2.1 Yabang Company Information
- 8.2.2 Yabang Business Overview
- 8.2.3 Yabang Oxyclozanide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Yabang Oxyclozanide Product Portfolio
- 8.2.5 Yabang Recent Developments
- 8.3 Gharda
- 8.3.1 Gharda Company Information
- 8.3.2 Gharda Business Overview
- 8.3.3 Gharda Oxyclozanide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Gharda Oxyclozanide Product Portfolio
- 8.3.5 Gharda Recent Developments
- 8.4 ASCENT PHARMA
- 8.4.1 ASCENT PHARMA Company Information
- 8.4.2 ASCENT PHARMA Business Overview
- 8.4.3 ASCENT PHARMA Oxyclozanide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 ASCENT PHARMA Oxyclozanide Product Portfolio
- 8.4.5 ASCENT PHARMA Recent Developments
- 8.5 Aarambh Life Science
- 8.5.1 Aarambh Life Science Company Information
- 8.5.2 Aarambh Life Science Business Overview
- 8.5.3 Aarambh Life Science Oxyclozanide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Aarambh Life Science Oxyclozanide Product Portfolio
- 8.5.5 Aarambh Life Science Recent Developments
- 8.6 ProVentus
- 8.6.1 ProVentus Company Information
- 8.6.2 ProVentus Business Overview
- 8.6.3 ProVentus Oxyclozanide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 ProVentus Oxyclozanide Product Portfolio
- 8.6.5 ProVentus Recent Developments
- 8.7 Excel Industries
- 8.7.1 Excel Industries Company Information
- 8.7.2 Excel Industries Business Overview
- 8.7.3 Excel Industries Oxyclozanide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Excel Industries Oxyclozanide Product Portfolio
- 8.7.5 Excel Industries Recent Developments
- 8.8 Konar Organics
- 8.8.1 Konar Organics Company Information
- 8.8.2 Konar Organics Business Overview
- 8.8.3 Konar Organics Oxyclozanide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Konar Organics Oxyclozanide Product Portfolio
- 8.8.5 Konar Organics Recent Developments
- 8.9 Neha Pharma
- 8.9.1 Neha Pharma Company Information
- 8.9.2 Neha Pharma Business Overview
- 8.9.3 Neha Pharma Oxyclozanide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Neha Pharma Oxyclozanide Product Portfolio
- 8.9.5 Neha Pharma Recent Developments
- 8.10 D. H. Organics
- 8.10.1 D. H. Organics Company Information
- 8.10.2 D. H. Organics Business Overview
- 8.10.3 D. H. Organics Oxyclozanide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 D. H. Organics Oxyclozanide Product Portfolio
- 8.10.5 D. H. Organics Recent Developments
- 8.11 Neeta Interchem
- 8.11.1 Neeta Interchem Company Information
- 8.11.2 Neeta Interchem Business Overview
- 8.11.3 Neeta Interchem Oxyclozanide Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Neeta Interchem Oxyclozanide Product Portfolio
- 8.11.5 Neeta Interchem Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Oxyclozanide Value Chain Analysis
- 9.1.1 Oxyclozanide Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Oxyclozanide Production Mode & Process
- 9.2 Oxyclozanide Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Oxyclozanide Distributors
- 9.2.3 Oxyclozanide Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst